PM&R
Volume 2, Issue 4 , Pages 282-284, April 2010

Safety Considerations in the Use of Botulinum Toxins in Children With Cerebral Palsy

  • Susan D. Apkon, MD

      Affiliations

    • Department of Rehabilitation Medicine, University of Washington; and Department of Rehabilitation Medicine, Seattle Children's, M/S W-9847, PO Box 5371, Seattle, WA⁎
    • Corresponding Author InformationAddress correspondence to S.D.A.
    • ,
  • Danielle Cassidy, PharmD

      Affiliations

    • Investigational Drug Services & Anticoagulation Clinical Pharmacist, The Children's Hospital, Denver, CO†

Received 22 December 2009; accepted 17 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1934-1482(10)00131-0

doi:10.1016/j.pmrj.2010.02.006

PM&R
Volume 2, Issue 4 , Pages 282-284, April 2010

Article Tools